open access

Vol 52, No 5 (2021)
Clinical vignette
Submitted: 2021-05-16
Accepted: 2021-06-18
Published online: 2021-10-28
Get Citation

Primary central nervous system lymphoma co-existing with ataxia–telangiectasia syndrome

Agnieszka Mizia-Malarz1, Weronika Stolpa1, Magdalena Zalała2, Bartosz Zwiernik2, Mateusz Marszałek2
DOI: 10.5603/AHP.2021.0093
·
Acta Haematol Pol 2021;52(5):522-524.
Affiliations
  1. Department of Pediatrics, Upper Silesia Children’s Care Heatlh Centre, Medical University of Silesia, Medykow Street 16, 40-758 Katowice, Poland
  2. Medical University of Silesia, Medykow Street, Katowice, Poland

open access

Vol 52, No 5 (2021)
CLINICAL VIGNETTE
Submitted: 2021-05-16
Accepted: 2021-06-18
Published online: 2021-10-28

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

primary central nervous system lymphoma, ataxia-telangiectasia syndrome, children

About this article
Title

Primary central nervous system lymphoma co-existing with ataxia–telangiectasia syndrome

Journal

Acta Haematologica Polonica

Issue

Vol 52, No 5 (2021)

Article type

Clinical vignette

Pages

522-524

Published online

2021-10-28

DOI

10.5603/AHP.2021.0093

Bibliographic record

Acta Haematol Pol 2021;52(5):522-524.

Keywords

primary central nervous system lymphoma
ataxia-telangiectasia syndrome
children

Authors

Agnieszka Mizia-Malarz
Weronika Stolpa
Magdalena Zalała
Bartosz Zwiernik
Mateusz Marszałek

References (10)
  1. Abla O, Weitzman S, Blay JY, et al. Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG). Clin Cancer Res. 2011; 17(2): 346–352.
  2. Kai Y, Kuratsu J, Ushio Y. Primary malignant lymphoma of the brain in childhood. Neurol Med Chir (Tokyo). 1998; 38(4): 232–237.
  3. Attarbaschi A, Abla O, Ronceray L, et al. Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents. Blood Adv. 2019; 3(24): 4291–4297.
  4. Küker W, Nägele T, Korfel A, et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol. 2005; 72(2): 169–177.
  5. Han CH, Bathelor TT. Diagnosis and management of primary central nervous system lymphoma. Cancer. 2017; 123(22): 4314–4324.
  6. Giulino-Roth L, Abla O, Batchelor TT. Management of primary central nervous system lymphoma in children. Hematology Am Soc Hematol Educ Program. 2016; 2016(1): 386–389.
  7. Kim SeH, Cheong JW, Park KH, et al. Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin. Arch Pathol Lab Med. 2007; 131(3): 457–467.
  8. Rothblum-Oviatt C, Wright J, Lefton-Greif MA, et al. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016; 11(1): 159.
  9. Attarbaschi A, Carraro E, Abla O, et al. European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Study Group. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents. Haematologica. 2016; 101(12): 1581–1591.
  10. Verhoeven D, Stoppelenburg AJ, Meyer-Wentrup F, et al. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy. Clin Immunol. 2018; 190: 22–31.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl